The Herbal Science Hub

Amalaki (Phyllanthus emblica L., syn. Emblica officinalis Gaertn.), known in English as Indian Gooseberry, is a small deciduous tree of the Phyllanthaceae family native to the Indian subcontinent. Its fruit is exceptionally rich in vitamin C — reported at approximately 300–700 mg per 100 g of fresh fruit depending on variety and ripeness, among the highest concentrations found in any commonly consumed fruit. Beyond vitamin C, the fruit contains a distinctive polyphenol profile including emblicanin A and B (unique hydrolysable tannins specific to this species), gallic acid, ellagic acid, corilagin, and various flavonoids. Amalaki is classified in Ayurveda as one of the most important Rasayana (rejuvenative) substances and is the eponymous component of Amalaki Rasayana — a specific classical anti-ageing protocol. It is also one of the three fruits in Triphala, the most widely used Ayurvedic compound formula. A 2023 systematic review and meta-analysis of five randomised controlled trials confirmed Amalaki supplementation improves total cholesterol, LDL cholesterol, and fasting glucose in adults, alongside individual trials showing benefit for dyslipidaemia, endothelial function, and oxidative stress markers in type 2 diabetes.

Ashwagandha (Withania somnifera (L.) Dunal) is a small evergreen shrub of the Solanaceae family, native to the dry regions of India. Its roots contain withanolides — a class of steroidal lactones of which withaferin A and withanolide D are the most pharmacologically studied. Among the five herbs with Rasayana classification in classical Ayurveda, Ashwagandha has the most extensive modern human clinical trial database, with randomised controlled trials (RCTs) confirming statistically significant reductions in serum cortisol, improvements in validated stress and anxiety scales, increases in testosterone in men with suboptimal baseline levels, and gains in muscle strength and recovery. A post-marketing hepatotoxicity signal — small but real — has been identified in case reports and requires explicit disclosure.

Daruharidra (Berberis aristata DC.) is a thorny deciduous shrub of the Berberidaceae family, native to the sub-Himalayan forests of India and Nepal. Its stem bark and roots are the primary commercial source of berberine — an isoquinoline alkaloid with documented glucose-lowering, lipid-lowering, and antimicrobial pharmacology. Berberine activates adenosine monophosphate-activated protein kinase (AMPK), the cellular energy sensor that regulates glucose uptake and fatty acid oxidation. A 2015 meta-analysis of 46 randomised controlled trials found berberine's glucose-lowering effect comparable in magnitude to that of first-line oral antidiabetics, with a distinct mechanism of action that makes combination with metformin pharmacologically rational but requires pharmacokinetic monitoring due to a confirmed transporter interaction. Ayurveda classified Daruharidra as a Pramehaghna (anti-diabetic) dravya in Charaka Samhita over 2,000 years before the AMPK pathway was described.

Guduchi (Tinospora cordifolia (Willd.) Miers) is a large deciduous climbing shrub of the Menispermaceae family, widely distributed across tropical India. Known as Giloy in Hindi and Amrita (immortal nectar) in Sanskrit — a name reflecting its historically revered status as a Rasayana (rejuvenative) herb — Guduchi is the most extensively used immunomodulatory herb in Ayurvedic medicine. Its stem contains a complex mixture of protoberberine alkaloids, furanoid diterpenoid lactones, and an arabinogalactan polysaccharide (G1-4A) that activates macrophages, increases phagocytic activity, and modulates cytokine production. Clinical evidence for immunomodulation, anti-allergic, and anti-diabetic activity is emerging but limited by small sample sizes and methodological heterogeneity. The herb carries a critical safety signal: a 2021 AIIMS New Delhi case series linked Guduchi Ghana (concentrated dry extract) to autoimmune hepatitis — a serious adverse event that has not been resolved and requires explicit disclosure in all clinical contexts. Guduchi is one of the most searched Ayurvedic herbs in India following COVID-19 and is included in the Ministry of AYUSH's COVID-19 management protocol — making accurate, evidence-based information about its efficacy and safety limits especially important.

Haritaki (Terminalia chebula Retz.) is a large deciduous tree of the Combretaceae family, native to South and Southeast Asia. Its dried ripe fruit — called chebulic myrobalan in English — is classified in classical Ayurvedic texts as one of the most versatile and important single medicinal substances, earning the title Pathya (suitable for all conditions) and Abhaya (fearless, implying use without contraindication across most constitutions). The fruit contains an exceptionally high concentration of hydrolysable tannins — chebulagic acid, chebulinic acid, and corilagin — alongside ellagic acid and gallic acid, collectively accounting for 30–40% of the fruit's dry weight. These polyphenols account for its documented antioxidant, anti-inflammatory, alpha-glucosidase inhibitory, and antimicrobial activities. Published human clinical studies confirm benefits for skin quality, gut microbiome composition, and joint discomfort. It is one of the three constituent fruits of Triphala (three fruits), the most widely used Ayurvedic compound formula globally. Human clinical evidence for Haritaki as a single herb is limited but expanding, with multiple trials completed in 2022–2024.

Kutki (Picrorhiza kurroa Royle ex Benth.) is a small perennial herb of the Plantaginaceae family, native to the alpine Himalayas. Its dried rhizome is one of the most important hepatoprotective (liver-protecting) agents in classical Ayurvedic medicine, where it is classified as a premier Tikta (bitter) and Bhedana (purgative) drug. The rhizome contains a standardised iridoid glycoside fraction — collectively termed kutkin or picroliv — composed primarily of picroside I and picroside II (also called kutkoside). These compounds account for the documented antioxidant, anti-cholestatic, and liver-protective activities demonstrated across numerous in vitro and animal studies. The strongest human evidence comes from a randomised, double-blind, placebo-controlled trial in patients with acute viral hepatitis (Vaidya et al., 1996), which showed significantly faster resolution of jaundice with Kutki compared to placebo. Kutki is also used traditionally for respiratory conditions, fever, and skin disorders, though human evidence for these indications is weaker or, in the case of asthma, contradicted by controlled data. Picrorhiza kurroa is an endangered species requiring conservation-conscious sourcing.

Manjistha (Rubia cordifolia L.), known in English as Indian Madder, is a climbing perennial herb of the Rubiaceae family whose dried root is one of the most widely used single herbs in Ayurvedic dermatology. Classically termed a Raktashodhaka (blood purifier), Manjistha is prescribed across a wide range of inflammatory skin conditions including acne, pigmentation, eczema, and wounds, and is a defining ingredient in the classical formulation Kumkumadi Taila, still one of the most commercially recognised Ayurvedic skin oils globally. Its root contains a distinctive anthraquinone pigment profile, most notably purpurin and munjistin, alongside naphthohydroquinones including mollugin, furomollugin, and rubilactone. Laboratory research has demonstrated tyrosinase-inhibitory activity (relevant to skin pigmentation), antibacterial activity against acne-associated bacteria, antiviral activity against hepatitis B surface antigen in liver cell culture, antiulcer activity, and — in a notable 2023 study — protection against sepsis in a mouse model via inhibition of the TAK1-NF-kB inflammatory pathway. Despite this substantial laboratory and animal research base, only one human clinical trial has been published to date: a 2020 randomised, double-blind, placebo-controlled pilot study from the University of California, Davis, examining Manjistha's effect on the human gut microbiome, which found highly individualised responses without a clear, consistent pattern across participants. Manjistha shares its genus with Rubia tinctorum (European Madder), a related species whose anthraquinone compound lucidin has documented genotoxic and carcinogenic activity in long-term rodent studies, prompting regulatory restriction in Germany — a safety consideration this profile addresses directly given the shared plant chemistry.

Methi (Trigonella foenum-graecum L.), known in English as Fenugreek, is an annual herb of the Fabaceae (legume) family whose small, hard, yellowish-brown seeds are one of the most researched single ingredients in Ayurvedic and global ethnomedicine for blood glucose management. The seed's bioactive profile is dominated by a furostanolic saponin fraction alongside the amino acid 4-hydroxyisoleucine and a high soluble fibre (galactomannan) content, together proposed to slow carbohydrate absorption, stimulate insulin secretion, and improve insulin sensitivity. A 2025 updated systematic review and meta-analysis pooling 26 randomised controlled trials found significant improvements in fasting blood glucose, 2-hour postprandial glucose, HbA1c, and insulin resistance (HOMA-IR), building on an earlier foundational 2014 meta-analysis with similar findings. Fenugreek's other major traditional use — as a galactagogue to increase breast milk supply — has a much thinner and more mixed modern evidence base, with major lactation-support organisations stating that current data are insufficient to confirm efficacy or fully characterise safety for the nursing infant. A 2020s RCT investigating testosterone effects in men found increases versus baseline but only a marginal, mostly non-significant effect versus placebo at typical doses. Fenugreek carries a well-documented uterine-stimulant effect in both traditional use and preclinical research, making pregnancy avoidance an important and well-established safety point.

Pippali (Piper longum L.) is a climbing perennial vine of the Piperaceae family, cultivated across tropical India and Southeast Asia for its dried immature fruit spikes. Its primary active compound, piperine, is a piperidine alkaloid that inhibits cytochrome P450 3A4 (CYP3A4) and P-glycoprotein (P-gp) — two of the body's most important drug metabolism and efflux systems. This dual inhibition forms the pharmacological basis for piperine's role as a bioavailability enhancer, documented in a human study to increase curcumin absorption by 2,000% (Shoba et al., 1998, Planta Med). A 2024 physiologically based pharmacokinetic modelling study predicted that 20 mg/day piperine increases the area under the curve (AUC) of simvastatin by 59%, cyclosporine by 35%, and multiple other CYP3A4 substrates significantly. Pippali is a primary ingredient in Trikatu (three pungents) — the most widely used classical Ayurvedic bioavailability-enhancing formula — alongside dry ginger (Shunthi) and black pepper (Maricha). It is prescribed across classical Ayurvedic texts for respiratory, digestive, and metabolic conditions, but it carries a clinically important herb-drug interaction profile that must be disclosed to patients taking pharmaceutical medications.

Shallaki (Boswellia serrata Roxb. ex Colebr.) is an oleo-gum resin-producing deciduous tree of the Burseraceae family, native to the dry forests of India and widely used in Ayurvedic medicine for over 3,000 years. The tree is tapped by incision of the bark to produce a pale-yellow to amber resin that contains a characteristic series of pentacyclic triterpenic acids — the boswellic acids — of which 3-O-acetyl-11-keto-β-boswellic acid (AKBA) is the primary pharmacologically active constituent. Shallaki is classified in Ayurveda as a Shothahara (anti-inflammatory) and Vedanasthapana (analgesic) dravya. Modern pharmacological research has confirmed that AKBA selectively inhibits the enzyme 5-lipoxygenase (5-LOX), thereby reducing production of pro-inflammatory leukotrienes — a mechanism distinct from, and complementary to, that of non-steroidal anti-inflammatory drugs (NSAIDs). Three double-blind, randomised controlled trials have demonstrated clinically meaningful improvement in knee osteoarthritis outcomes. One Phase II clinical trial has shown reduction of peritumoral brain oedema. Unlike NSAIDs, Boswellia extract does not inhibit cyclooxygenase (COX-1 or COX-2), thereby sparing prostaglandins involved in gastric mucosal protection.

Shankhpushpi (Convolvulus pluricaulis Choisy) is a small prostrate annual herb of the Convolvulaceae family, native to the dry plains of India. It is one of four herbs classified as Medhya Rasayana (cognitive rejuvenatives) in Charaka Samhita — the only classical category specifically designated for enhancing intellect, memory, and mental function. Its phytochemical profile includes alkaloids (shankhapushpine, convoline, convolamine), flavonoids (kaempferol, quercetin), steroids (beta-sitosterol), and glycosides. Animal model evidence for anxiolytic, nootropic, and neuroprotective activity is consistent and mechanistically supported. Human clinical evidence is sparse, methodologically limited, and complicated by a persistent botanical identification problem — commercial Shankhpushpi preparations frequently contain substitute species rather than authentic Convolvulus pluricaulis, making interpretation of published clinical studies unreliable without authenticated botanical source documentation.

Shatavari (Asparagus racemosus Willd.) is a climbing thorny shrub of the Asparagaceae family, native to tropical India and the Himalayan foothills. Its fasciculated tuberous roots are the principal medicinal part, containing steroidal saponins — chiefly the shatavarin series — as primary bioactive compounds. Shatavari holds the status of the principal female reproductive tonic in Ayurvedic medicine, referenced as Strishreshtha (the best herb for women) in classical texts. Its name translates loosely as 'she who has a hundred husbands' — reflecting the traditional understanding of its reproductive and vitality-restoring properties. Pharmacologically, shatavarin-derived aglycones demonstrate selective affinity for oestrogen receptor beta (ERβ), providing a mechanistic basis for its documented effects on lactation, menopausal symptom relief, and uterine function. Clinical evidence is emerging but limited — the strongest data are for galactagogue (lactation-promoting) effect and menopausal symptom relief, each supported by small randomised controlled trials that require replication in larger studies.

Vacha (Acorus calamus) is a primary Ayurvedic nervine and cognitive enhancer characterised by its high volatile oil content, primarily alpha- and beta-asarone. Pharmacologically, it demonstrates potent GABAergic neuromodulation and neuroprotective activity in preclinical models. Its clinical use is restricted due to the established hepatocarcinogenicity of beta-asarone in animal models, requiring specific purification (Shodhana) or use of beta-asarone-free chemotypes.

Vidanga (Embelia ribes Burm.f.), known in English as False Black Pepper for its resemblance to black peppercorns, is a climbing shrub of the Myrsinaceae family whose dried, ripe, reddish-brown to black fruit is one of the most historically important single herbs in Ayurvedic medicine. It is classified as Krimighna (worm-destroying) in classical texts and remains the principal Ayurvedic herb prescribed for intestinal parasitic infestation, including tapeworm, roundworm, and threadworm. Its primary bioactive compound, embelin (2,5-dihydroxy-3-undecyl-1,4-benzoquinone), is a naturally occurring benzoquinone that has been the subject of extensive pharmacological research into antiparasitic, antidiabetic, anti-inflammatory, antioxidant, antitumor, and neuroprotective activity — almost entirely in animal models, cell culture, and in vitro enzyme systems. Embelin is officially recognised as one of 32 Ayurvedic drugs of national importance by India's National Medicinal Plant Board. Despite this substantial body of preclinical research and an unbroken classical use history spanning Charaka Samhita and Sushruta Samhita, no published human randomised controlled trial evaluating Vidanga or embelin for any indication has been identified in the current literature. This is an important gap for anyone considering Vidanga, and it distinguishes this herb from others in this database with stronger human clinical support.

Yashtimadhu (Glycyrrhiza glabra), known in English as Licorice, is one of the most widely used herbs in both Ayurveda and global traditional medicine, valued particularly for soothing the digestive tract, throat, and respiratory system. A 2025 Phase III randomised controlled trial confirmed a specific flavonoid-rich licorice extract significantly relieved acid reflux symptoms, and a 2025 meta-analysis of 9 studies supported its use in peptic ulcer. However, licorice carries one of the most serious and best-documented safety profiles of any common herb: its compound glycyrrhizin can raise blood pressure and dangerously lower potassium, with published case reports of life-threatening heart rhythm problems. European food safety authorities advise no more than 100 mg of glycyrrhizin daily. Deglycyrrhizinated licorice (DGL) largely removes this risk and is the form used in most modern clinical trials.